Chinese english Germany Japanese Korea

3-phenylimidazo[1,2-a]pyrazine

3-phenylimidazo[1,2-a]pyrazine Struktur
126052-34-4
CAS-Nr.
126052-34-4
Englisch Name:
3-phenylimidazo[1,2-a]pyrazine
Synonyma:
3-PHENYLIMIDAZO[1,2;3-phenylimidazo[1,2-a]pyrazine;2-PhenyliMidazo[1,2-a]pyrazine;IMidazo[1,2-a]pyrazine, 2-phenyl-
CBNumber:
CB82525077
Summenformel:
C12H9N3
Molgewicht:
195.22
MOL-Datei:
126052-34-4.mol
Request For Quotation

3-phenylimidazo[1,2-a]pyrazine Eigenschaften

Schmelzpunkt:
132-134℃
Dichte
1.21±0.1 g/cm3(Predicted)
storage temp. 
2-8°C
pka
3.48±0.30(Predicted)

Sicherheit

3-phenylimidazo[1,2-a]pyrazine Chemische Eigenschaften,Einsatz,Produktion Methoden

3-phenylimidazo[1,2-a]pyrazine Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

3-phenylimidazo[1,2-a]pyrazine Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 29)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
Alchem Pharmtech,Inc. 		8485655694
sales@alchempharmtech.com United States 63711 58
career henan chemical co 		+86-0371-86658258 +8613203830695
 factory@coreychem.com China 29825 58
CR Corporation Lomited
fred.wen@crcorporation.cn CHINA 12069 58
Huadong Medicine (Xi'an)Bodyguard Pharmaceutical Co.,Ltd. 		+86-029-86185165 +8618629664246
 guoyuan@eastchinapharm.com China 1615 58
Golden Pharma Co., Limited 		+undefined18958062155
 sales@zjgoldpharm.com China 5905 58
Amadis Chemical Company Limited 		571-89925085
sales@amadischem.com China 131980 58
Meryer (Shanghai) Chemical Technology Co., Ltd. 021-61259108 18621169085
 market03@meryer.com China 40240 62
Wuhan Luohua Medical Technology Co.,Ltd. 13477084141; 13477084141
 sales@luohuapharm.com China 469 60
Shanghai Ennopharm Co., Ltd. +86 (21) 6435-5022
China 4271 65
NovoChemy Ltd. 021-31261262/ 49 (0)17662837245
sales@novochemy.com Germany 6331 58
  • 3-phenylimidazo[1,2-a]pyrazine
  • IMidazo[1,2-a]pyrazine, 2-phenyl-
  • 2-PhenyliMidazo[1,2-a]pyrazine
  • 3-PHENYLIMIDAZO[1,2
  • 126052-34-4
Copyright 2019 © ChemicalBook. All rights reserved